(Q35614308)

9 August 2017

1 reference

title

Preventing cardiovascular disease in diabetes and glucose intolerance: evidence and implications for care (English)

1 reference

9 August 2017

cardiovascular disease

1 reference

1 reference

Nancy J Rennert

1

1 reference

PubMed ID

14692202

9 August 2017

Pamela Charney

series ordinal

2

1 reference

9 August 2017

1 September 2003

1 reference

Primary Care: Clinics in Office Practice

9 August 2017

1 reference

9 August 2017

30

1 reference

9 August 2017

3

1 reference

9 August 2017

569-592

1 reference

Diabetes and decline in heart disease mortality in US adults.

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

U.K. Prospective Diabetes Study 27. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Blood glucose concentrations < or = 125 mg/dl and coronary heart disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Diabetes mellitus and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Impact of history of diabetes mellitus on hospital mortality in men and women with first acute myocardial infarction. The National Registry of Myocardial Infarction 2 Participants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

In-hospital and 1-year mortality in 1,524 women after myocardial infarction. Comparison with 4,315 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Ten-year survival after acute myocardial infarction: comparison of patients with and without diabetes. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Role of diabetes in congestive heart failure: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

1 reference

7 January 2021

Risk Factors for Stroke in Type 2 Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Carotid artery atherosclerosis in type-2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (The Insulin Resistance Atherosclerosis Study)

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Diabetes mellitus as a risk factor for death from stroke. Prospective study of the middle-aged Finnish population.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn Study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Prevalence of impaired glucose tolerance among children and adolescents with marked obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Ethnic variation in cardiovascular disease risk factors among children and young adults: findings from the Third National Health and Nutrition Examination Survey, 1988-1994

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Cardiovascular risk factors in ethnic minority women aged < or =30 years

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

The importance of diagnosing the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Insulin and the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Polycystic ovary syndrome: a risk for coronary artery disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Cardiovascular disease prevention practices by U.S. Physicians for patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Modifiable cardiovascular risk factors in adults with diabetes: prevalence and missed opportunities for physician counseling

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

The prognostic value of blood glucose in diabetic patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Inf

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Intensive insulin therapy in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Smoking and risk of coronary heart disease among women with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Relative and Absolute Excess Risks of Coronary Heart Disease among Women Who Smoke Cigarettes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

A diabetes report card for the United States: quality of care in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Nicotine metabolism and intake in black and white smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Postural hypotension and postural dizziness in patients with non-insulin-dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study).

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Treatment of diabetic dyslipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Clinical practice. Nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

The benefits of lowering cholesterol in subjects with mild hyperglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Obesity rising to alarming levels around the world.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Behavioral counseling in primary care to promote physical activity: recommendation and rationale

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Diet and exercise in the treatment of obesity: effects of 3 interventions on insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

The effect of hormone replacement therapy on cardiovascular risk factors in type 2 diabetes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Improving the adverse cardiovascular prognosis of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Comprehensive evaluation of community-based diabetic patients: effect of feedback to patients and their physicians: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900035-6

7 January 2021

10.1016/S0095-4543(03)00035-6

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14692202